XML 58 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Long-Term Investments (Details 4) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Net sales $ 115,553 $ 197,733 $ 420,852 $ 601,757
Gross profit 106,934 194,936 404,038 584,109
Share of losses from investments accounted for using the equity method $ 665 (38,272)
BioFirst [Member]        
Net sales     134,759 32,235
Gross profit     6,397 5,048
Net loss     (4,936,294) (842,838)
Share of losses from investments accounted for using the equity method     (1,067,298) (182,113)
Rgene [Member]        
Net sales     16,449
Gross profit     (332,763)
Net loss     (441,678) (59,717)
Share of losses from investments accounted for using the equity method